Hormonal contraceptive prescriptions in the UK Armed Forces. Issue 1 (18th January 2021)

• Record Type: Journal Article
• Authors: Double, Rebecca L; Wardle, S L; O'Leary, T J; Weaden, N; Bailey, G; Greeves, J P
• Is Part Of: BMJ military health. Volume 169:Issue 1(2023)
• Page Start: 23
• Page End: 26
• Publication Date: 2021-01-18
• Subjects: audit -- physiology -- reproductive medicine; Medicine, Military -- Periodicals; Military hygiene -- Periodicals; 355.345
• DOI: 10.1136/bmjmilitary-2020-001594
• Languages: English
• ISSNs: 2633-3767

Abstract

Abstract : Introduction: Thirty four per cent of women use hormonal contraceptives in the UK and the contraceptive pill is the most common method. There are no comparable data in the UK Armed Forces, but servicewomen are often required to complete physically arduous job roles in combat zones and may be more likely to take contraceptives to control or stop menstrual bleeding than the general population. We explored the prevalence of hormonal contraceptive prescriptions in the UK Armed Forces. Methods: The study used defence medical records (Defence Medical Information Capability Programme) to identify hormonal contraceptive prescriptions for all serving regular UK servicewomen (n=15 738) as of 1 September 2017. Results: Thirty one per cent of servicewomen (Royal Navy, 28%; British Army, 30%; Royal Air Force, 34%) had a current prescription for a hormonal contraceptive. Non-officer ranks were more likely to have a prescription for a hormonal contraceptive (32%) than officers (27%) (p<0.01). The contraceptive pill was more commonly prescribed (68%) than long-acting reversible contraceptive methods (32%) (contraceptive injection, 11%; contraceptive implant, 11%; intrauterine device, 10%). Conclusion: Prescription data suggest that the prevalence of hormonal contraceptive use in UK servicewomen is comparable with the general UK population. These findings suggest that military service does not influence prevalence or choice of hormonal contraceptives.